The effect of prenatal and early childhood nutritional supplementation on infant and early childhood body composition, growth and development (ENID-Growth)
|ING Staff:||Momodou Darboe, Sophie Moore, Andrew Prentice|
The primary objective of this trial is to determine the effect of a balanced protein-energy and micronutrient nutritional supplement during pregnancy and a subsequent lipid-base nutrient supplement (LNS) supplementation in infancy and early childhood on child body composition, growth and motor development. The trial will also explore the potential physiological mechanisms that may underlie the growth effects of the supplement. This is an add-on to the ENID Trial, extending the period of infant supplementation from 12 to 18 months of age, and following the infants until they reach 24 months of age. Primary outcome measures will include detailed and frequent infant anthropometry and body composition, and the achievement of both gross and fine motor milestones.